KALBE FARMAKALBE FARMAKALBE FARMA

KALBE FARMA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪59.76 T‬IDR
‪2.77 T‬IDR
‪30.45 T‬IDR
‪18.64 B‬
Beta (1Y)
0.70
Employees (FY)
‪13.11 K‬
Change (1Y)
+384 +3.02%
Revenue / Employee (1Y)
‪2.32 B‬IDR
Net income / Employee (1Y)
‪211.07 M‬IDR

About KALBE FARMA


CEO
Bernadette Ruth Setiady
Headquarters
Jakarta
Founded
1966
ISIN
ID1000125107
FIGI
BBG000BFRVS5
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KLBF is 1,275 IDR — it has decreased by −3.41% in the past 24 hours. Watch KALBE FARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange KALBE FARMA stocks are traded under the ticker KLBF.
KLBF stock has fallen by −12.67% compared to the previous week, the month change is a −10.84% fall, over the last year KALBE FARMA has showed a −21.05% decrease.
We've gathered analysts' opinions on KALBE FARMA future price: according to them, KLBF price has a max estimate of 2,040.00 IDR and a min estimate of 1,550.00 IDR. Watch KLBF chart and read a more detailed KALBE FARMA stock forecast: see what analysts think of KALBE FARMA and suggest that you do with its stocks.
KLBF reached its all-time high on Feb 13, 2023 with the price of 2,360 IDR, and its all-time low was 70 IDR and was reached on Oct 28, 2008. View more price dynamics on KLBF chart.
See other stocks reaching their highest and lowest prices.
KLBF stock is 6.43% volatile and has beta coefficient of 0.70. Track KALBE FARMA stock price on the chart and check out the list of the most volatile stocks — is KALBE FARMA there?
Today KALBE FARMA has the market capitalization of ‪58.84 T‬, it has decreased by −4.32% over the last week.
Yes, you can track KALBE FARMA financials in yearly and quarterly reports right on TradingView.
KALBE FARMA is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
KLBF earnings for the last quarter are 12.32 IDR per share, whereas the estimation was 14.93 IDR resulting in a −17.48% surprise. The estimated earnings for the next quarter are 16.33 IDR per share. See more details about KALBE FARMA earnings.
KLBF net income for the last quarter is ‪573.28 B‬ IDR, while the quarter before that showed ‪847.54 B‬ IDR of net income which accounts for −32.36% change. Track more KALBE FARMA financial stats to get the full picture.
Yes, KLBF dividends are paid annually. The last dividend per share was 31.00 IDR. As of today, Dividend Yield (TTM)% is 2.43%. Tracking KALBE FARMA dividends might help you take more informed decisions.
KALBE FARMA dividend yield was 1.93% in 2023, and payout ratio reached 51.83%. The year before the numbers were 1.82% and 52.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪13.11 K‬ employees. See our rating of the largest employees — is KALBE FARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KALBE FARMA EBITDA is ‪4.67 T‬ IDR, and current EBITDA margin is 14.20%. See more stats in KALBE FARMA financial statements.
Like other stocks, KLBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KALBE FARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KALBE FARMA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KALBE FARMA stock shows the sell signal. See more of KALBE FARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.